Foxo1-flox Mouse
一般名
Foxo1-flox
製品ID
S-CKO-17420
背景情報
C57BL/6NCya
系統ID
CKOCMP-56458-Foxo1-B6N-VA
状況
このマウス系統を論文で使用する場合は、「Foxo1-flox Mouse(カタログ番号S-CKO-17420)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Foxo1-flox
系統ID
CKOCMP-56458-Foxo1-B6N-VA
遺伝子名
製品ID
S-CKO-17420
遺伝子別名
Afxh, FKHR, Fkhr1, Foxo1a
遺伝子別名
C57BL/6NCya
NCBI ID
修正
Conditional knockout
染色体
Chr 3
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000053764
NCBIトランスクリプトID
NM_019739
ターゲット領域
Exon 2
有効領域の大きさ
~1.9 kb
遺伝子研究の概要
FoxO1, short for Forkhead box O1, is a crucial transcription factor that mediates insulin→PI3K→Akt signaling, governing diverse cellular processes such as cell cycle arrest, apoptosis, and DNA repair [3,6]. It is involved in multiple biological functions like metabolism, cell differentiation, and maintaining tissue homeostasis, and is associated with various diseases including fibrosis, diabetes, obesity, and cancers [3,4,5,6,7]. Genetic models, especially KO/CKO mouse models, are valuable in studying its functions.
In endometrial research, FoxO1 is considered a decidualization marker in endometrial stromal cells as it regulates the transcription of decidual prolactin and insulin-like growth factor-binding protein 1 genes. Epithelial FoxO1 is a novel endometrial receptivity marker, and its loss of function causes endometrial neoplasia. In endothelium, its expression coincides with increased vascular permeabilization during early pregnancy [1].
In liver fibrosis studies, increased FoxO1 expression and activation were observed in carbon tetrachloride (CCL4)-induced fibrosis. Hepatic FoxO1 deletion in F1KO mice largely attenuated CCL4-induced liver injury, fibrosis, inflammation, and decreased TGF-β1 levels compared to control mice [3].
In age-related osteoporosis, FOXO1 signaling, which is downregulated in aging macrophages, plays a key role. Blocking FOXO1 signaling aggravates bone loss and macrophage senescence, while lipoteichoic acid treatment elevates FOXO1 signaling via the β-catenin pathway [2].
In the intestine, FOXO1 deficiency in ILC3s drives hyperactivation and gut inflammation. FOXO1 promotes the transcription of neuropeptide receptor VIPR2 and inhibits ADRA2A, balancing ILC3s activation [8].
In conclusion, FoxO1 is essential for maintaining physiological functions in multiple tissues. Model-based research, especially KO/CKO mouse models, has revealed its significant roles in endometrial remodeling, liver fibrosis, osteoporosis, and intestinal homeostasis. Understanding FoxO1 functions provides potential therapeutic targets for related diseases such as endometrial neoplasia, liver fibrosis, and age-related osteoporosis [1,2,3,8].
References:
1. Adiguzel, Dileyra, Celik-Ozenci, Ciler. . FoxO1 is a cell-specific core transcription factor for endometrial remodeling and homeostasis during menstrual cycle and early pregnancy. In Human reproduction update, 27, 570-583. doi:10.1093/humupd/dmaa060. https://pubmed.ncbi.nlm.nih.gov/33434267/
2. Cheng, Weike, Fu, Yong, Lin, Zexin, Yu, Bin, Liu, Guanqiao. 2023. Lipoteichoic acid restrains macrophage senescence via β-catenin/FOXO1/REDD1 pathway in age-related osteoporosis. In Aging cell, 23, e14072. doi:10.1111/acel.14072. https://pubmed.ncbi.nlm.nih.gov/38126583/
3. Pan, Quan, Gao, Mingming, Kim, DaMi, Qi, Yajuan, Guo, Shaodong. 2023. Hepatocyte FoxO1 Deficiency Protects From Liver Fibrosis via Reducing Inflammation and TGF-β1-mediated HSC Activation. In Cellular and molecular gastroenterology and hepatology, 17, 41-58. doi:10.1016/j.jcmgh.2023.08.013. https://pubmed.ncbi.nlm.nih.gov/37678798/
4. Xin, Zhenlong, Ma, Zhiqiang, Hu, Wei, Jia, Guozhan, Yang, Yang. 2017. FOXO1/3: Potential suppressors of fibrosis. In Ageing research reviews, 41, 42-52. doi:10.1016/j.arr.2017.11.002. https://pubmed.ncbi.nlm.nih.gov/29138094/
5. Shi, Feiyu, Li, Tian, Liu, Zhi, Xia, Hongping, She, Junjun. 2017. FOXO1: Another avenue for treating digestive malignancy? In Seminars in cancer biology, 50, 124-131. doi:10.1016/j.semcancer.2017.09.009. https://pubmed.ncbi.nlm.nih.gov/28965871/
6. Ebrahimnezhad, Mohammad, Natami, Mohammad, Bakhtiari, Ghazaleh Hafezi, Yousefi, Bahman, Majidinia, Maryam. 2023. FOXO1, a tiny protein with intricate interactions: Promising therapeutic candidate in lung cancer. In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 169, 115900. doi:10.1016/j.biopha.2023.115900. https://pubmed.ncbi.nlm.nih.gov/37981461/
7. Benchoula, Khaled, Arya, Aditya, Parhar, Ishwar S, Hwa, Wong Eng. 2020. FoxO1 signaling as a therapeutic target for type 2 diabetes and obesity. In European journal of pharmacology, 891, 173758. doi:10.1016/j.ejphar.2020.173758. https://pubmed.ncbi.nlm.nih.gov/33249079/
8. Shao, Fei, Liu, Zhen, Wei, Qinglin, Fan, Zusen, Wang, Shuo. 2023. FOXO1 orchestrates the intestinal homeostasis via neuronal signaling in group 3 innate lymphoid cells. In The Journal of experimental medicine, 220, . doi:10.1084/jem.20230133. https://pubmed.ncbi.nlm.nih.gov/37549024/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
